
[ Thu, Sep 23rd 2021 ]: WOPRAI

[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI

[ Tue, Sep 21st 2021 ]: WOPRAI
Oren Livnat Maintained (VRCA) at Strong Buy with Decreased Target to $20 on, Sep 22nd, 2021


🞛 This publication is a summary or evaluation of another publication
Oren Livnat of HC Wainwright & Co., Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Decreased Target from $24 to $20 on, Sep 22nd, 2021.
Oren has made no other calls on VRCA in the last 4 months.
There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Oren's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Oren
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $16 on, Tuesday, September 21st, 2021
- Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, September 21st, 2021